Single-cell analysis highlights the significance of malignant cell IFN/MHC-II for immunotherapy response in head and neck squamous cell carcinoma

Michael Mints(Karolinska Institutet), Sidharth V. Puram(Washington University in St. Louis), Jessica Ley(Washington University in St. Louis), Fudong Wang(Washington University in St. Louis), Alissa Greenwald(University of Toronto), Ryan S. Jackson(Washington University in St. Louis), W. L. Thorstad(Washington University in St. Louis), Salma Ramadan(Washington University in St. Louis), R. Alex Harbison(Washington University in St. Louis), Patrik Pipkorn(Washington University in St. Louis), Ashley N. Reeb(Washington University in St. Louis), Riley Mullins(Washington University in St. Louis), Reilly A. Sample(Washington University in St. Louis), Anuraag S. Parikh(Columbia University Irving Medical Center), Randal C. Paniello, Thomas F. Barrett(Washington University in St. Louis), Jesse M. Zaretsky(Washington University in St. Louis), Sophie P. Gerndt(Washington University in St. Louis), Zongtai Qi(Washington University in St. Louis), Emily Stoller(University of Massachusetts Chan Medical School), D. Adkins(Washington University in St. Louis), R. Uppaluri(Dana-Farber Cancer Institute), Jason T. Rich(Washington University in St. Louis), Peter Oppelt(Washington University in St. Louis), Travis Law(Broad Institute), Paul A. Zolkind(Washington University in St. Louis), Itay Tirosh(Weizmann Institute of Science)
Cell Reports Medicine
March 31, 2026
Cited by 1


Related Papers